(HealthDay)—In patients with head and neck cancer (HNC), the prevalence of mental health disorders (MHDs) is significantly higher after cancer diagnosis, according to a study published online Feb. 28 in JAMA Otolaryngology-Head ...
Mar 1, 2019
0
3
A team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) has found an epigenetic modification that might be the cause of 15% of adult cancers of the throat linked to alcohol and tobacco ...
Jan 11, 2017
0
39
Asian head and neck cancer patients live longer with the immunotherapy pembrolizumab than the overall population, according to a sub-analysis of the KEYNOTE-012 trial presented at the ESMO ASIA 2016 Congress in Singapore.
Dec 15, 2016
0
27
Patients treated with IMRT for head and neck cancer report an increasingly better quality of life post-treatment when compared to patients receiving other forms of radiation therapy, according to a study presented at the ...
Jan 26, 2012
0
0
Up to half of patients with head and neck squamous cell carcinoma will experience tumor recurrence or new tumors—tumors that often spread and are difficult to treat.
May 26, 2021
0
11
Patients undergoing primary radiotherapy treatment with or without chemotherapy, rather than surgery, for head and neck cancers are more likely to experience delays in their treatment starting, according to a new analysis ...
Feb 14, 2022
0
3
A new American Cancer Society guideline provides clinicians with recommendations on key areas of clinical follow-up care for survivors of head and neck cancer, a growing population numbering approximately 436,060 and accounting ...
Mar 22, 2016
0
3
A targeted therapy drug used for breast and kidney cancers may also extend progression-free survival for patients with advanced head and neck cancer who are at high risk for recurrence after standard treatment. Patients enrolled ...
Feb 27, 2020
0
0
(HealthDay)—For post-radiotherapy survivors of head and neck cancer, depression is fairly common, but treatment is underutilized, according to research published online Aug. 15 in JAMA Otolaryngology-Head & Neck Surgery.
Aug 16, 2013
0
0
A University of Cincinnati study found administering an immunotherapy drug before surgery for oral cavity cancer did not lead to increased rates of complications during and after surgery.
Sep 7, 2022
0
10
